BIOT

Biotech Acquisition Company Class A Ordinary Shares
BIOT

Overview Fund Activity
Delisted

BIOT was delisted on the 2nd of February, 2023.

Back to rankings

28 hedge funds and large institutions have $70M invested in Biotech Acquisition Company Class A Ordinary Shares in 2021 Q1 according to their latest regulatory filings, with 28 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
+28
Holders Change %
–
% of All Funds
0.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
CCP
Corbin Capital Partners
New York
$9.02M
2
Citadel Advisors
Citadel Advisors
Florida
$8.69M
3
MI
MMCAP International
Cayman Islands
$5.83M
4
PAMP
Polar Asset Management Partners
Ontario, Canada
$5.83M
5
ACM
Atalaya Capital Management
New York
$5.4M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Shares
Change %
EAM
26
Exos Asset Management
New York
$242K +$242K +25,000 New
WAM
27
Wolverine Asset Management
Illinois
$16K +$16K +1,673 New
1
2